{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:44:36Z","timestamp":1792928676377,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81272524"],"award-info":[{"award-number":["81272524"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773021"],"award-info":[{"award-number":["81773021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.bcp.2024.116040","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T23:41:31Z","timestamp":1706917291000},"page":"116040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin"],"prefix":"10.1016","volume":"221","author":[{"given":"Jun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlai","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.bcp.2024.116040_b0005","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1056\/NEJMoa1910962","article-title":"Niraparib in patients with newly diagnosed advanced ovarian cancer","volume":"381","author":"Gonzalez-Martin","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/15548627.2014.998931","article-title":"TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer","volume":"11","author":"Zhang","year":"2015","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.bcp.2024.116040_b0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2024.116040_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111824","article-title":"New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities","volume":"141","author":"Ashrafizadeh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2024.116040_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100881","article-title":"Paclitaxel resistance related to nuclear envelope structural sturdiness","volume":"65","author":"Smith","year":"2022","journal-title":"Drug Resist. Updat."},{"issue":"49","key":"10.1016\/j.bcp.2024.116040_b0030","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1038\/s41388-021-01941-z","article-title":"A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML)","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bcp.2024.116040_b0035","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41388-021-02143-3","article-title":"CD147 supports paclitaxel resistance via interacting with RanBP1","volume":"41","author":"Nan","year":"2022","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-22-0423","article-title":"JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states","volume":"83","author":"Stevens","year":"2023","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neo.2018.12.005","article-title":"MicroRNA-503-5p inhibits the CD97-mediated JAK2\/STAT3 pathway in metastatic or paclitaxel-resistant ovarian cancer cells","volume":"21","author":"Park","year":"2019","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.bcp.2024.116040_b0050","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1158\/1535-7163.MCT-11-0072","article-title":"B7\u2013H3 silencing increases paclitaxel sensitivity by abrogating Jak2\/Stat3 phosphorylation","volume":"10","author":"Liu","year":"2011","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.bcp.2024.116040_b0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41568-022-00537-3","article-title":"STAT proteins in cancer: orchestration of metabolism","volume":"23","author":"Li","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.bcp.2024.116040_b0060","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2024.116040_b0065","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1038\/s41467-020-17920-z","article-title":"Selective inhibition of STAT3 signaling using monobodies targeting the coiled-coil and N-terminal domains","volume":"11","author":"La Sala","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bcp.2024.116040_b0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1083\/jcb.200503021","article-title":"Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin","volume":"172","author":"Ng","year":"2006","journal-title":"J. Cell Biol."},{"issue":"18","key":"10.1016\/j.bcp.2024.116040_b0080","doi-asserted-by":"crossref","first-page":"12349","DOI":"10.1074\/jbc.M807761200","article-title":"STAT3-stathmin interactions control microtubule dynamics in migrating T-cells","volume":"284","author":"Verma","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2024.116040_b0085","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/0008-5472.CAN-16-1115","article-title":"The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116040_b0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1186\/s12885-020-07274-6","article-title":"TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells","volume":"20","author":"Escalona","year":"2020","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.bcp.2024.116040_b0095","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1158\/1078-0432.CCR-06-0861","article-title":"Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer","volume":"12","author":"Duan","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41419-020-2327-1","article-title":"ID1 confers cancer cell chemoresistance through STAT3\/ATF6-mediated induction of autophagy","volume":"11","author":"Meng","year":"2020","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.bcp.2024.116040_b0105","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1124\/mol.107.038117","article-title":"8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells","volume":"72","author":"Duan","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0110","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1158\/1078-0432.CCR-15-1169","article-title":"Inhibition of the EGFR\/STAT3\/CEBPD axis reverses cisplatin cross-resistance with paclitaxel in the urothelial carcinoma of the urinary bladder","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2024.116040_b0115","doi-asserted-by":"crossref","unstructured":"R. Siersbaek, V. Scabia, S. Nagarajan, I. Chernukhin, E.K. Papachristou, R. Broome, S.J. Johnston, S.E.P. Joosten, A.R. Green, S. Kumar, J. Jones, S. Omarjee, R. Alvarez-Fernandez, S. Glont, S.J. Aitken, K. Kishore, D. Cheeseman, E.A. Rakha, C. D'Santos, W. Zwart, A. Russell, C. Brisken, J.S. Carroll, IL6\/STAT3 Signaling Hijacks Estrogen Receptor alpha Enhancers to Drive Breast Cancer Metastasis, Cancer Cell 38(3) (2020) 412-423 e9.","DOI":"10.1016\/j.ccell.2020.06.007"},{"issue":"23","key":"10.1016\/j.bcp.2024.116040_b0120","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1158\/0008-5472.CAN-07-0593","article-title":"WP1066 disrupts Janus kinase-2 and induces caspase-dependent apoptosis in acute myelogenous leukemia cells","volume":"67","author":"Ferrajoli","year":"2007","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.bcp.2024.116040_b0125","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/bph.15441","article-title":"Identification of WP1066, an inhibitor of JAK2 and STAT3, as a K(V) 1.3 potassium channel blocker","volume":"178","author":"Li","year":"2021","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2024.116040_b0130","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/sj.bjc.6605691","article-title":"STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma","volume":"102","author":"Horiguchi","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"17","key":"10.1016\/j.bcp.2024.116040_b0135","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1038\/sj.onc.1210031","article-title":"A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo","volume":"26","author":"Iwamaru","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2015.01.021","article-title":"The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6","volume":"359","author":"Lu","year":"2015","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bcp.2024.116040_b0145","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.4238\/2015.March.30.3","article-title":"Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro","volume":"14","author":"Tang","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116040_b0150","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4143\/crt.2016.175","article-title":"Adipose stromal cells from visceral and subcutaneous fat facilitate migration of ovarian cancer cells via IL-6\/JAK2\/STAT3 pathway","volume":"49","author":"Kim","year":"2017","journal-title":"Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.bcp.2024.116040_b0155","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1074\/jbc.M307261200","article-title":"Regulation of microtubule destabilizing activity of Op18\/stathmin downstream of Rac1","volume":"279","author":"Wittmann","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2024.116040_b0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13058-015-0564-5","article-title":"Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents","volume":"17","author":"Ong","year":"2015","journal-title":"Breast cancer research : BCR"},{"issue":"10","key":"10.1016\/j.bcp.2024.116040_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103141","article-title":"Interleukin-6 promotes microtubule stability in axons via Stat3 protein-protein interactions","volume":"24","author":"Wareham","year":"2021","journal-title":"iScience"},{"issue":"4","key":"10.1016\/j.bcp.2024.116040_b0170","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41401-021-00718-0","article-title":"The novel STAT3 inhibitor WZ-2-033 causes regression of human triple-negative breast cancer and gastric cancer xenografts","volume":"43","author":"Zhong","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.bcp.2024.116040_b0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1089\/dna.2014.2713","article-title":"STAT3 association with microtubules and its activation are independent of HDAC6 activity","volume":"34","author":"Yan","year":"2015","journal-title":"DNA Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116040_b0180","first-page":"13","article-title":"STAT3 inhibition by microtubule-targeted drugs: dual molecular effects of chemotherapeutic agents","volume":"3","author":"Walker","year":"2011","journal-title":"Mol. Cell. Pharm."},{"key":"10.1016\/j.bcp.2024.116040_b0185","article-title":"Tubulin post-translational modifications: potential therapeutic approaches to heart failure","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"7312","key":"10.1016\/j.bcp.2024.116040_b0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature09324","article-title":"MEC-17 is an alpha-tubulin acetyltransferase","volume":"467","author":"Akella","year":"2010","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.bcp.2024.116040_b0195","doi-asserted-by":"crossref","first-page":"R1287","DOI":"10.1016\/j.cub.2017.10.044","article-title":"Causes and consequences of microtubule acetylation","volume":"27","author":"Janke","year":"2017","journal-title":"Curr. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116040_b0200","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1091\/mbc.e10-03-0203","article-title":"A novel acetylation of \u03b2-tubulin by San modulates microtubule polymerization via down-regulating tubulin incorporation","volume":"22","author":"Chu","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"9","key":"10.1016\/j.bcp.2024.116040_b0205","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1074\/jbc.273.9.4928","article-title":"Microtubule-interfering agents activate c-Jun N-terminal kinase\/stress-activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways","volume":"273","author":"Wang","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2024.116040_b0210","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1074\/jbc.274.12.8208","article-title":"Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells","volume":"274","author":"Wang","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bcp.2024.116040_b0215","doi-asserted-by":"crossref","first-page":"15640","DOI":"10.1074\/jbc.M900343200","article-title":"Regulation of microtubule dynamic instability in vitro by differentially phosphorylated stathmin","volume":"284","author":"Manna","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.bcp.2024.116040_b0220","doi-asserted-by":"crossref","first-page":"10053","DOI":"10.1074\/jbc.M109.044420","article-title":"Regulation of microtubule dynamics through phosphorylation on stathmin by Epstein-Barr virus kinase BGLF4","volume":"285","author":"Chen","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"34","key":"10.1016\/j.bcp.2024.116040_b0225","doi-asserted-by":"crossref","first-page":"36063","DOI":"10.18632\/oncotarget.5373","article-title":"Septin cooperation with tubulin polyglutamylation contributes to cancer cell adaptation to taxanes","volume":"6","author":"Froidevaux-Klipfel","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bcp.2024.116040_b0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41420-021-00453-9","article-title":"Tubulin acetylation enhances lung cancer resistance to paclitaxel-induced cell death through Mcl-1 stabilization","volume":"7","author":"Wattanathamsan","year":"2021","journal-title":"Cell Death Discov"},{"issue":"22","key":"10.1016\/j.bcp.2024.116040_b0235","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1007\/s00018-015-2000-5","article-title":"Tubulin acetylation: responsible enzymes, biological functions and human diseases","volume":"72","author":"Li","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116040_b0240","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41580-020-0214-3","article-title":"The tubulin code and its role in controlling microtubule properties and functions","volume":"21","author":"Janke","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224000236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:47:31Z","timestamp":1757771251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224000236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":48,"alternative-id":["S0006295224000236"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116040","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WP1066, a small molecule inhibitor of STAT3, chemosensitizes paclitaxel-resistant ovarian cancer cells to paclitaxel by simultaneously inhibiting the activity of STAT3 and the interaction of STAT3 with Stathmin","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116040"}}